MLPRX Stock Overview
Engages in the manufacture and sale of antibacterial/antimicrobial plastic products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Parx Materials N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.32 |
| 52 Week High | €0.64 |
| 52 Week Low | €0.06 |
| Beta | 0.032 |
| 11 Month Change | 95.06% |
| 3 Month Change | 125.71% |
| 1 Year Change | -47.33% |
| 33 Year Change | -68.40% |
| 5 Year Change | -89.81% |
| Change since IPO | -91.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLPRX | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | 9.7% | -2.1% | -1.9% |
| 1Y | -47.3% | 10.4% | 1.9% |
Return vs Industry: MLPRX underperformed the French Chemicals industry which returned 10.4% over the past year.
Return vs Market: MLPRX underperformed the French Market which returned 1.9% over the past year.
Price Volatility
| MLPRX volatility | |
|---|---|
| MLPRX Average Weekly Movement | 27.4% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.1% |
Stable Share Price: MLPRX's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: MLPRX's weekly volatility has increased from 17% to 27% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Michael van der Jagt | www.parxmaterials.com |
Parx Materials N.V. engages in the manufacture and sale of antibacterial/antimicrobial plastic products worldwide. The company offers its products are effective against bacteria, viruses, biofilm, mold and fungi, clogging, bad odor, fouling, and infections used in food contact and packaging, implants and medical devices, textiles, pipes and drainages, and anti-fouling applications. It holds a patented technology under the Saniconcentrate name.
Parx Materials N.V. Fundamentals Summary
| MLPRX fundamental statistics | |
|---|---|
| Market cap | €3.29m |
| Earnings (TTM) | -€35.66k |
| Revenue (TTM) | €167.31k |
19.7x
P/S Ratio-92.4x
P/E RatioIs MLPRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLPRX income statement (TTM) | |
|---|---|
| Revenue | €167.31k |
| Cost of Revenue | €190.84k |
| Gross Profit | -€23.53k |
| Other Expenses | €12.14k |
| Earnings | -€35.66k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0034 |
| Gross Margin | -14.06% |
| Net Profit Margin | -21.32% |
| Debt/Equity Ratio | 0% |
How did MLPRX perform over the long term?
See historical performance and comparison